Considering the pivotal role cholesterol plays in myelination of the central nervous system [55], future research is warranted to test possible differences in the constituency of breast milk or lipid metabolism, as a function of FMR1 mutation size, that could affect developmental outcomes in FXS. Here, FMR1 is linked to fragile X syndrome.